Extended Data Fig. 4: Trends between ISG or HLA class II expression scores and clinical parameters in total PBMCs. | Nature Medicine

Extended Data Fig. 4: Trends between ISG or HLA class II expression scores and clinical parameters in total PBMCs.

From: A single-cell atlas of the peripheral immune response in patients with severe COVID-19

Extended Data Fig. 4: Trends between ISG or HLA class II expression scores and clinical parameters in total PBMCs.

a, b, Scatter plots depicting the correlation between (a) the mean ISG expression score or (b) the mean HLA class II expression score and patient age, days from fever onset, or days post-symptom onset (Supplementary Table 25). For all plots, only n = 8 COVID-19 patient samples are included. For plots depicting correlations with days from fever onset, n = 6 as the two COVID-19 patients who never reported fever (C6 and C7) are excluded. Pearson correlation coefficients, exact two-sided p-values, and the 95% confidence interval are shown for each comparison.

Back to article page